1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour : A Translational Perspective
- Contribution to journal › Scientific review
-
Mark
Agreement between relatives of Parkinson's patients and clinical observer in home diary assessments
(2026) In Journal of Parkinson's Disease
- Contribution to journal › Article
- 2025
-
Mark
Recognition, management, and patient perspectives of impulsive-compulsive disorders in Parkinson's disease
- Contribution to journal › Article
-
Mark
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease : A Randomized Clinical Trial
- Contribution to journal › Article
- 2024
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
- Contribution to journal › Article
- 2023
-
Mark
Time to workforce exit after a Parkinson's disease diagnosis
- Contribution to journal › Article
-
Mark
Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
- Contribution to journal › Article
-
Mark
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
- Contribution to journal › Scientific review
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
- Contribution to journal › Article
